Abstract:Background Gene therapy using a recombinant adenovirus (Ad) encoding secretory human endostatin (Ad-Endo) has been demonstrated to be a promising antiangiogenesis and antitumor strategy of in animal models and clinical trials. The E1B55KD-deficient Ad dl 1520 was also found to replicate selectively in and destroy cancer cells. In this study, we aimed to investigate the antitumor effects of antiangiogenic agent Ad-Endo combined with the oncolytic Ad dl 1520 on gastric cancer (GC) in vitro and in vivo and determine the mechanisms of these effects. Methods The Ad DNA copy number was determined by real-time PCR, and gene expression was assessed by ELISA, Western blotting or immunohistochemistry. The anti-proliferation effect (cytotoxicity) of Ad was assessed using the colorimetry-based MTT cell viability assay. The antitumor effects were evaluated in BALB/c nude mice carrying SGC-7901 GC xenografts. The microvessel density and Ad replication in tumor tissue were evaluated by checking the expression of CD34 and hexon proteins, respectively. Results dl 1520 replicated selectively in GC cells harboring an abnormal p53 pathway, including p53 mutation and the loss of p14 ARF expression, but did not in normal epithelial cells. In cultured GC cells, dl 1520 rescued Ad-Endo replication, and dramatically promoted endostatin expression by Ad-Endo in a dose- and time-dependent manner. In turn, the addition of Ad-Endo enhanced the inhibitory effect of dl 1520 on the proliferation of GC cells. The transgenic expression of Ad5 E1A and E1B19K simulated the rescue effect of dl 1520 supporting Ad-Endo replication in GC cells. In the nude mouse xenograft model, the combined treatment with dl 1520 and Ad-Endo significantly inhibited tumor angiogenesis and the growth of GC xenografts through the increased endostatin expression and oncolytic effects. Conclusions Ad-Endo combined with dl 1520 has more antitumor efficacy against GC than Ad-Endo or dl 1520 alone. These findings indicate that the combination of Ad-mediated antiangiogenic gene therapy and oncolytic Ad therapeutics could be one of promising comprehensive treatment strategies for GC.

Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma

E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies.

Combination of Adenoviruses Expressing Melanoma Differentiation-Associated Gene-7 and Chemotherapeutic Agents Produces Enhanced Cytotoxicity on Esophageal Carcinoma

Combined Use of Chemotherapeutics and Oncolytic Adenovirus in Treatment of AFP-expressing Hepatocellular Carcinoma

Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status

Synergistic Effect of Bladder Cancer-Specific Oncolytic Adenovirus in Combination with Chemotherapy.

Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin

Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism]

In Vitro Study on Combination of Oncolytic Adenovirus and Ad - Endo Against Cervical Carcinoma

Tumor-specific Cytolysis Caused by an E1B55K-attenuated Adenovirus in Nasopharyngeal Carcinoma is Augmented by Cisplatin.

[Adenovirus-Mediated PDCD5 Gene Transfer Sensitizes Apoptosis of K562 Cells Induced by Etoposide].

Inhibitory Effects of 5-Aza-2′-deoxycytidine and Trichostatin A in Combination with P53-Expressing Adenovirus on Human Laryngocarcinoma Cells

Antitumor Efficacy of a Recombinant Adenovirus Encoding Endostatin Combined with an E1B55KD-deficient Adenovirus in Gastric Cancer Cells

Synergistic Killing Effect of the Conditionally Replicating Adenoviruses Carrying Programmed Cell Death 5 Gene and Etoposide on K562 Cells

Combination of recombinant adenovirus encoding mCD40L gene therapy with 5-Fu improves therapeutic efficacy of murine carcinoma

Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine.

The combination of NK and CD8+T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells

Apoptosis Effects of ODC and AdoMetDC Biantisense Virus on Esophageal Cancer Cell Eca109

Effects of Combinative Application of Nedaplatin and Cispaltin on the Proliferation and Apoptosis of Human Esophageal Squamous Carcinoma Eca-109 Cell Line

Effect of Combined Treatment of Radiation and Tissue-Specific Recombinant Oncolytic Adenovirus on Bladder Cancer Cells

In Vitro Effect of Recombinant Human Adenovirus p53 Combined with Epirubicin on Human Gastric Cancer Cells